The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 21, 2020

Filed:

Oct. 19, 2012
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

B. Chia Soo, Beverly Hills, CA (US);

Kang Ting, Beverly Hills, CA (US);

Zhong Zheng, Van Nuys, CA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/34 (2006.01); A61L 31/16 (2006.01); A61L 31/06 (2006.01); A61L 27/54 (2006.01); A61C 8/00 (2006.01); A61L 31/10 (2006.01); A61F 2/30 (2006.01); A61F 2/44 (2006.01);
U.S. Cl.
CPC ...
A61L 31/06 (2013.01); A61C 8/0016 (2013.01); A61L 27/34 (2013.01); A61L 27/54 (2013.01); A61L 31/10 (2013.01); A61L 31/16 (2013.01); A61F 2/4455 (2013.01); A61F 2002/3084 (2013.01); A61F 2310/0052 (2013.01); A61F 2310/0097 (2013.01); A61F 2310/00359 (2013.01); A61F 2310/00365 (2013.01); A61F 2310/00976 (2013.01); A61L 2300/104 (2013.01); A61L 2300/404 (2013.01); A61L 2400/12 (2013.01);
Abstract

Implant-associated bacterial infections are one of the most serious complications in orthopedic surgery. Treatment of these infections often requires multiple operations, device removal, long-term systemic antibiotics, and extended rehabilitation, and is frequently ineffective, leading to worse clinical outcomes and increased financial costs. Silver nanoparticle/poly(DL-lactic-co-glycolic acid) (PLGA)-coated stainless steel alloy (SNPSA) was evaluated as a potential antimicrobial implant material. It was found that SNPSA exhibited strong antibacterial activity in vitro and ex vivo, and promoted MC3T3-E1 pre-osteoblasts proliferation and maturation in vitro. Furthermore, SNPSA implants induced osteogenesis while suppressing bacterial survival in contaminated rat femoral canals. The results indicate that SNPSA has simultaneous antimicrobial and osteoinductive properties that make it a promising therapeutic material in orthopedic surgery.


Find Patent Forward Citations

Loading…